Treatment Horizons

Therapeutic Vaccine Research Toward a Functional Cure Shows Promise by Jeannie Wraight Until recently, therapeutic vaccines and immune-based therapies (IBTs) were all but shunned by the...

An extended release formulation breaks through by Chael Needle Based on results from the VERxVE study, the FDA recently approved Viramune XR for use in antiretroviral...

Is better HIV treatment related to improved survival after an individual is diagnosed with an AIDS-defining opportunistic illness (AIDS-OI)? That was one of the...

Treatment Horizons by Chael Needle A nonprofit creates a new support system for the uninsured Joining Merck and ViiV Healthcare, Gilead Sciences is now supporting and...

Protecting One's Heart The REPRIEVE study aims to prevent cardiovascular disease by Chael Needle As people are living longer with HIV, researchers have been increasingly attending to...

A Treatment for Lipodystrophy-Related Excessive Abdominal Fat Comes of Age by Chael Needle HIV-associated lipodystrophy, abnormalities in metabolism and/or distribution of fat in those living with...

Could breast milk possibly be protective against HIV? by Chael Needle The benefits of breastfeeding in resource-poor countries while mothers and infants are on differently tailored...

The Deeper End of the Ocean Host restrictive factors create research excitement by Mariel Selbovitz, MPH, and David Miller The doors on viral host restrictive factors (HRFs),...

Warts & All An immunotherapy candidate seeks to address complications from HPV by Chael Needle Human papillomavirus (HPV) is the most common sexually transmitted infection, but, according...

LifeGuide A community perspective on PrEP delves into its pros & cons by Jeannie Gibbs Post-exposure prophylaxis (PrEP) is the provision of antiretrovirals (ARVs) to HIV-negative...